Sort   by:  
 Page size 
Resistance to endocrine treatments and CDK4/6 inhibitors is considered a near-inevitability in most patients with estrogen receptor positive breast cancers (ER + BC). By genomic and metabolomics analyses of patients' tumours, metastasis-derived patient-derived xenografts (PDX) and isogenic cell line...
2023-06-27 | MTBLS3342 | MetaboLights
Spatial transcriptomics analysis of urticarial rash skin from patients with Schnitzler syndrome
We conducted a multicenter, open-label, single-arm phase II trial (SCan Study) to evaluate the efficacy and safety of canakinumab in 5 Japanese patients with Schnitzler syndrome (SchS), based on a similar study conducted in Germany. As part of this study, spatial transcriptomics of urticarial rash s...
ORGANISM(S): Homo sapiens 
2025-04-21 | GSE292123 | GEO
We conducted a multicenter, open-label, single-arm phase II trial (SCan Study) to evaluate the efficacy and safety of canakinumab in 5 Japanese patients with Schnitzler syndrome (SchS), based on a similar study conducted in Germany. In this trial, single-cell RNA sequencing (scRNA-seq) of peripheral...
ORGANISM(S): Homo sapiens 
2025-04-21 | GSE292122 | GEO
Single-cell RNA sequencing of peripheral blood from Schnitzler syndrome patients before and after canakinumab treatment
Sort   by:  
 Page size